Effect of GBA gene variants on clinical characteristics of dementia with Lewy bodies: a review and meta-analyses
- 24 March 2022
- journal article
- review article
- Published by Springer Nature in Neurological Sciences
- Vol. 43 (6) , 3541-3550
Abstract
Objectives Glucocerebrosidase (GBA) gene may be a risk factor for dementia with Lewy bodies (DLB). However, due to the small number of existing studies and the small sample size of previous investigations, it is necessary to conduct objective and quantitative analyses of the association between GBA variants and DLB. There is no consensus regarding the relationship between GBA and the clinical characteristics of DLB. Therefore, we conducted multiple systematic reviews and meta-analyses with a particular focus on the age of onset, sex, and cognitive impairment. Methods PubMed, Cochrane, and EMBASE databases were searched to retrieve related studies. The odds ratios and 95% confidence interval were calculated to determine the association between GBA and DLB and between GBA and the clinical characteristics of DLB. Results Our meta-analysis confirmed that the GBA variant rate was significantly higher in the DLB group than in the control group, as were the variant rates of L444P, N370S, and E326K, whereas the variant rate of T369M showed no significant difference between the groups. Furthermore, the relevant literature was summarised again for meta-analyses. The GBA variant group had a younger age of onset and lower Montreal Cognitive Assessment score than the GBA non-variant group in DLB patients. GBA variants do not differ between sexes in DLB patients. Conclusions GBA variants increased the risk of DLB, especially N370S, E326K, and L444P which are strongly associated with DLB, but T369M was not. Patients harbouring GBA variants have an earlier age of onset, more severe cognitive impairment, and rapid symptom progression; however, sex is irrelevant in DLB.Keywords
Funding Information
- To explore the function and mechanism of CACNA1C gene in the pathogenesis of spinocerebellar ataxia based on the CaM/CaMKII/CREB pathway (No.20200201451JC)
- Jilin Province Center for Precision Medicine Diagnosis and Treatment of Nervous System Diseases (No.20200602045ZP)
This publication has 46 references indexed in Scilit:
- Risk factors for dementia with Lewy bodiesNeurology, 2013
- A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy BodiesJAMA Neurology, 2013
- -Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy BodiesJournal of Neuroscience, 2011
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Glucosidase-beta variations and Lewy body disordersParkinsonism & Related Disorders, 2009
- The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonismMovement Disorders, 2009
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseBrain, 2009
- Glucocerebrosidase Gene MutationsArchives of Neurology, 2008
- Hematologically important mutations: Gaucher diseaseBlood Cells, Molecules, and Diseases, 2005